Major improvement in treatment outcomes and quality of life of patients with multidrug-resistant tuberculosis (MDR-TB) are expected, following key changes in MDR-TB treatment announced by WHO in the Rapid Communication. The first important change is a new priority ranking of the available medicines for MDR-TB treatment, ...